Abstract:Human immunodeficiency virus type 1 (HIV-1) cannot be completely eliminated because of existence of the latent HIV-1 reservoir. However, the facts of HIV-1 latency, including its establishment and maintenance, are incomplete. FKBP3, encoded by the FKBP3 gene, belongs to the immunophilin family of proteins and is involved in immunoregulation and such cellular processes as protein folding. In a previous study, we found that FKBP3 may be related to HIV-1 latency using CRISPR screening. In this study, we knocked out the FKBP3 gene in multiple latently infected cell lines to promote latent HIV-1 activation. We found that FKBP3 could indirectly bind to the HIV-1 long terminal repeat through interaction with YY1, thereby recruiting histone deacetylase 1/2 to it. This promotes histone deacetylation and induces HIV-1 latency. Finally, in a primary latent cell model, we confirmed the effect of FKBP3 knockout on the latent activation of HIV-1. Our results suggest a new mechanism for the epigenetic regulation of HIV-1 latency and a new potential target for activating latent HIV-1. IMPORTANCE The primary reason why AIDS cannot be completely cured is the existence of a latent HIV-1 reservoir. Currently, the facts of HIV-1 latency, including its establishment and maintenance, are incomplete. Using a CRISPR library in our earlier screening of genes related to HIV-1 latency, we identified FBKP3 as a candidate gene related to HIV-1 latency. Therefore, in this mechanistic study, we first confirmed the HIV-1 latency-promoting effect of FKBP3 and determined that FKBP3 promotes histone deacetylation by recruiting histone deacetylase 1/2 to the HIV-1 long terminal repeat. We also confirmed, for the first time, that FKBP3 can act as a transcription factor (TF) recruitment scaffold and participate in epigenetic regulation of HIV-1 latency. These findings suggest a new mechanism for the epigenetic regulation of HIV-1 latency and a new potential target for activating latent HIV-1.

Retinoblastoma Binding Protein 4 Represses HIV-1 Long Terminal Repeat-Mediated Transcription by Recruiting NR2F1 and Histone Deacetylase.

Role of Retinoblastoma Protein-Associated Protein 48 (RBBP4) in HIV-1 Latency

RbAp48, a Novel Inhibitory Factor That Regulates the Transcription of Human Immunodeficiency Virus Type 1.

Effect of Retinoblastoma Binding Protein 4 (rbbp4)on Sp1-mediated Transcription of HIV Long Terminal Repeat in 293 T Cells

CBX4 Contributes to HIV-1 Latency by Forming Phase-Separated Nuclear Bodies and SUMOylating EZH2.

HIV-1 Downregulates the Expression and Phosphorylation of Receptor Tyrosine Kinase by Targeting the NF-κB Pathway

Identify Potential Regulators in Hiv-1 Latency by Joint Microrna and Mrna Analysis

PEBP 1 suppresses HIV transcription and induces latency by inactivating MAPK / NF ‐κB signaling

Increased Expression of BCL11B and Its Recruited Chromatin Remodeling Factors During Highly Active Antiretroviral Therapy Synergistically Represses the Transcription of Human Immunodeficiency Virus Type 1 and is Associated with Residual Immune Activation

FBXO34 Promotes Latent HIV-1 Activation by Post-Transcriptional Modulation

Scaffold Attachment Factor B Suppresses HIV-1 Infection of CD4+ T Cells by Preventing Binding of RNA Polymerase II to HIV-1's Long Terminal Repeat.

PADI4-mediated citrullination of histone H3 stimulates HIV-1 transcription

Role of TAR RNA Binding Protein in HIV-1 Infection

The receptor tyrosine kinase RON represses HIV-1 transcription by targeting RNA polymerase II processivity.

FKBP3 Induces Human Immunodeficiency Virus Type 1 Latency by Recruiting Histone Deacetylase 1/2 to the Viral Long Terminal Repeat

Neuropilin-1, a Myeloid Cell-Specific Protein, is an Inhibitor of HIV-1 Infectivity.

Transcriptional Suppression of the Human T-Cell Leukemia Virus Type I Long Terminal Repeat Occurs by an Unconventional Interaction of a CREB Factor with the R Region

Rbb, A Novel Transcription Repressor, Represses the Transcription of Hdm2 Oncogene

Ripretinib inhibits HIV-1 transcription through modulation of PI3K-AKT-mTOR

Modulation of BRD4 in HIV epigenetic regulation: implications for finding an HIV cure

Selective Histonedeacetylase Inhibitor M344 Intervenes in HIV-1 Latency Through Increasing Histone Acetylation and Activation of NF-kappaB.